# Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Tumor Stage 1 or 2, Nodes 0 (T1-T2 N0) Operable

> **NCT02855723** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 307 (actual)

## Conditions studied

- Head and Neck Tumors

## Interventions

- **OTHER:** Surgery: GS strategy
- **OTHER:** Surgery: Classic strategy

## Key facts

- **NCT ID:** NCT02855723
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 307 (ACTUAL)
- **Last updated:** 2016-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02855723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02855723, "Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Tumor Stage 1 or 2, Nodes 0 (T1-T2 N0) Operable". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02855723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*